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Three-Versus Two-Dimensional 
Sonographic Biometry for Predicting
Birth Weight and Macrosomia in 
Diabetic Pregnancies
etal macrosomia, defined as fetal weight exceeding 4000 or
4500 g regardless of gestational age, is associated with increased
risks of neonatal and maternal morbidity, including shoulder
dystocia, birth trauma, perineal lacerations, and cesarean delivery.1–4
Diabetes, especially when poorly controlled, is a major risk factor
for fetal macrosomia. This association is partially explained by exces-
sive growth from elevated maternal plasma glucose levels, resulting
in elevated fetal insulin and insulinlike growth factor levels, which
stimulate glycogen synthesis, fat deposition, and fetal growth.5,6
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Objectives—The purpose of this study was to test the hypothesis that a formula incor-
porating 3-dimensional (3D) fractional thigh volume would be superior to the con-
ventional 2-dimensional (2D) formula of Hadlock et al (Am J Obstet Gynecol 1985;
151:333–337) for predicting birth weight and macrosomia.
Methods—We conducted a prospective cohort study of pregnancies complicated by
pregestational or gestational diabetes and delivered after 38 weeks. Two-dimensional
and 3D sonographic examinations were performed for fetal biometry and factional thigh
volumes at 34 to 37 weeks. Fetal weight was estimated by Hadlock’s 2D formula IV,
which uses only 2D biometry, and formula 6 from Lee et al (Ultrasound Obstet Gynecol
2009; 34:556–565), which incorporates 3D fractional thigh volume and 2D biometry.
The gestation-adjusted projection method was used to estimate predicted birth weights
from 2D and 3D estimates. The primary outcome was fetal macrosomia, which was
defined as birth weight of 4000 g or higher. 
Results—A total of 115 women with diabetes met inclusion criteria, and 17 (14.8%)
delivered macrosomic neonates. The mean percentage error was significantly lower for
the 2D than the 3D projected estimate (1.0% versus 12.0%; P < .01). The standard
deviation of the mean percentage error was also significantly lower for the 2D projected
estimate (10.2% versus 17.2%; P < .01). Two-dimensional biometry was overall superior
to 3D biometry for predicting macrosomia (area under the receiver operating charac-
teristic curve, 0.88 versus 0.75; P = .03). Specificity was significantly higher for 2D
biometry (85% versus 66%; P < .01), whereas the difference in sensitivity was not
statistically significant (59% versus 71%; P = .22). 
Conclusions—In this study, the Hadlock 2D formula was superior to the 3D method for
predicting birth weight and macrosomia in diabetic women when used approximately
2 weeks before delivery, based on the gestation-adjusted projection method.
Key Words—diabetes; fetal macrosomia; fetal weight; obstetric ultrasound; 
3-dimensional sonography 
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Moreover, neonates of diabetic mothers of the same birth
weight are at higher risk for shoulder dystocia compared
to those of nondiabetic mothers because of different dis-
tributions of body fat.7,8 Thus, the American College of
Obstetricians and Gynecologists suggests consideration
of cesarean delivery for estimated fetal weight higher than
4500 g in women with diabetes and higher than 5000 g for
women without diabetes.9 This policy places a premium on
prenatal diagnosis of macrosomia, particularly in women
with diabetes, to inform obstetric care.
Despite its clinical value, accurate estimation of fetal
weight and prediction of macrosomia are challenging, with
substantial margins of error for both clinical estimates and
routine 2-dimensional (2D) sonographic biometry, espe-
cially at the extremes of fetal weight.10–13 Recent advances
in 3-dimensional (3D) sonography have shown promise
in improving fetal weight estimation over 2D sonography.
Lee et al14,15 demonstrated a significant improvement over
2D biometry when fractional thigh volume, a soft tissue
parameter based on 50% of the femur diaphysis length
from 3D sonography, was incorporated into 2D biometry.
Although this finding is promising, there are limited data
on the performance of 3D sonography for predicting
macrosomia in diabetic pregnancies.16 The objective of this
study was to test the hypothesis that incorporating 3D frac-
tional thigh volume would be superior to conventional 2D
biometry for predicting birth weight and macrosomia in
diabetic pregnancies.
Materials and Methods
We conducted a prospective cohort study of pregnancies
complicated by diabetes from 2005 to 2010 at Washington
University Medical Center. This work was part of a primary
study aimed at evaluating the ability of novel biomarkers
to predict fetal macrosomia in women with diabetes.
Approval was obtained from the Washington University
School of Medicine Human Research Protection Office
before initiation of the study. Informed consent was received
from all participants.
Women were eligible if they had pregestational type 2
or gestational diabetes, carried a singleton nonanomalous
fetus, and delivered after 38 weeks. Gestational diabetes
was diagnosed on the basis of universal 2-step screening
using a cutoff of 140 mg/dL on the 1-hour glucose challenge
test and the National Diabetes Data Group criteria on the
3-hour glucose tolerance test.17 Pregnancies were dated by
the women’s last menstrual periods and confirmed with
first- or second-trimester sonography using standard criteria.
All patients with diabetes routinely undergo sonography
for growth based on routine 2D biometry (head circum-
ference, biparietal diameter, abdominal circumference,
and femoral length) at 34 to 37 weeks. We performed
sonographic examinations at 34 to 37 weeks because
fetal sonographic biometry becomes less accurate nearer
the time of delivery, possibly because of descent of the
fetal head and a reduction in the amniotic fluid volume.
All sonographic examinations were performed by certified
registered diagnostic medical sonographers who were cre-
dentialed in obstetrics and gynecology. Diagnostic inter-
pretations were made by experienced sonologists and
maternal-fetal medicine attending physicians.
Three-dimensional thigh volumes were obtained at
the time of 2D biometry by 2 dedicated sonographers
using Voluson Expert 730 machines (GE Healthcare,
Milwaukee, WI), as previously described by Lee et al.14,15
Briefly, 3D multiplanar imaging was used to obtain thigh
volumes centered on the midpoint of the femur. At least 3
thigh volumes were taken per patient. Fractional thigh
volume measurements were obtained from the best volume
by a single physician, who was blinded to the birth weight, by
manually tracing around a central portion of the femoral
diaphysis using GE 4D View software. The fractional thigh
volumes were acquired twice, and the measurements
were averaged.
Fetal weights based on 2D biometry were estimated
by using formula IV from Hadlock et al18 (log10 2D esti-
mate = 1.5115 + 0.0436 [abdominal circumference] +
0.1517 [femur length] – 0.00321 [abdominal circumfer-
ence × femur length] + 0.0006923 [biparietal diameter ×
head circumference]). Three-dimensional formula 6 from
Lee et al,14 which incorporates 3D fractional thigh volume
and 2D biometric measurements (ln estimated weight =
–0.8297 + 4.0344 [ln biparietal diameter] – 0.7820 [ln bipari-
etal diameter] 2 + 0.7853 [ln abdominal circumference] +
0.0528 [ln fractional thigh volume]2) was also used to esti-
mate fetal weight. Since 2D and 3D measurements were
obtained a few weeks before delivery, we estimated pre-
dicted birth weights from 2D and 3D estimates using the
gestation-adjusted projection method described by
Mongelli and Gardosi.19 This extrapolation method is
based on the assumption that the ratio of fetal weight to
median weight for gestational age remains constant within
an interval of a few weeks in the third trimester.
The primary outcome measure was macrosomia,
defined as birth weight of 4000 g or higher, and the sec-
ondary outcome was birth weight of 4500 g or higher.
Descriptive characteristics were calculated for the cohort
and were compared for the presence or absence of macro-
somia by the χ2 test, Fisher exact test, Student t test, or
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Mann-Whitney U test as appropriate. The mean percent-
age error, a measure of systematic bias, was estimated
for predicted weight for 2D and 3D methods by using the
formula (projected estimate – actual birth weight]) ×
100/actual birth weight. The standard deviation of the
mean percentage error was estimated for each method as
a measure of random error. The mean percentage errors
and standard deviations for the two methods were com-
pared by the paired t test. Bland-Altman analysis was per-
formed, comparing the projected estimated weight from
each method to birth weight. The differences between birth
weight and the projected estimates (projected estimate –
birth weight) were plotted against birth weight. Systematic
bias, random error, and agreement were evaluated by the
mean absolute differences, standard deviations of the mean
differences, and 95% limits of agreement, respectively.20
Receiver operating characteristic (ROC) curves were
used to estimate the overall predictive ability of projected
2D and 3D estimates for macrosomia. The areas under the
ROC curves for the two groups were compared by using
the method described by DeLong et al.21 Predictive char-
acteristics (sensitivity, specificity, accuracy, positive pre-
dictive value [PPV], and negative predictive value [NPV])
were estimated for the two methods. Sensitivities and
specificities were compared by using an extension of the
McNemar test.22
All women meeting inclusion criteria during the study
period who provided consent were included; no a priori
sample size calculation was performed. All tests were 2 tailed,
with P < .05 considered significant. Statistical analyses were
completed with the Stata version 11 special edition soft-
ware package (StataCorp, College Station, TX). 
Results
A total of 115 women with diabetes met inclusion criteria
and had both 2D and 3D sonographic biometry. Most of
the cohort was African American, and two-thirds were
obese. One-third had gestational diabetes, and two-thirds
had pregestational diabetes. The mean gestational ages at
sonographic biometry and delivery were 37.5 and 39.5
weeks, respectively, with a 2-week average interval from bio-
metry to delivery (mean ± SD, 2.0 ± 1.5 weeks). There were
no significant differences in baseline characteristic between
women with and those without a macrosomic neonate
(Table 1).
The mean percentage error (measure of systematic
bias) was significantly lower for the 2D than the 3D pro-
jected estimate (1.0% [95% confidence interval (CI), 
–1.0%, 2.9%] versus 12.0% [95% CI, 8.9%, 15.2%]; P <
.01). The standard deviation of the mean percentage error
(measure of random error) was also significantly lower for
the 2D projected estimate (10.2% versus 17.2%; P < .01).
Bland-Altman analysis showed a lower mean difference
between the projected estimates and birth weight for 2D
biometry (14.9 versus 402.33 g; P < .01), suggesting less
systematic bias. The standard deviation of the mean dif-
ference was significantly lower for the 2D projected esti-
mates (373.8 versus 624.1 g; P < .01), indicating lower
random error. The 95% limits of agreements were wide
for both methods, but relatively narrower for 2D
projected estimates (–717.6 to +747.4 versus –820.8
to +1625.5 g), suggesting overall better agreement
between the 2D projected estimates and birth weight
(Figure 1).
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Table 1. Baseline Characteristics of the Study Participants 
Entire Cohort Macrosomia No Macrosomia
Characteristic (n = 115) (n = 17) (n = 98) P
Maternal age, y 29.4 ± 6.1 28.8 ± 5.8 29.5 ± 6.1 .67
Race, n (%) .28
African American 69 (60.0) 9 (52.9) 60 (61.2)
White 35 (30.4) 5 (29.4) 30 (30.6)
Latina/Hispanic 9 (7.8) 2 (11.8) 7 (7.1)
Other 2 (1.8) 1 (5.9) 1 (2.0)
Primiparous, n (%) 36 (31.3) 2 (11.8) 34 (34.7) .06
Body mass index, kg/m2 34.6 ± 9.5 33.6 ± 6.8 34.8 ± 9.9 .63
Obese (body mass index >30 kg/m2) 75 (65.2) 10 (58.8) 65 (66.3) .55
Diabetes type, n (%) .77
Pregestational 78 (67.8) 11 (64.7) 67 (68.4)
Gestational 37 (32.2) 6 (35.3) 31 (31.6)
Gestational age at sonography, wk 37.5 ± 1.3 37.7 ± 1.0 37.5 ± 1.4 .53
Gestational age at delivery, wk 39.5 ± 0.8 39.6 ± 0.7 39.5 ± 0.8 .95
Data are presented as mean ± SD where applicable.
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Seventeen of the 115 women (14.8%) delivered macro-
somic neonates with birth weights of 4000 g or higher
(primary outcome). Two-dimensional biometry was over-
all superior to 3D biometry for predicting macrosomia
(area under the ROC curve, 0.88 [95% CI, 0.80, 0.95]
versus 0.75 [95% CI, 0.60, 0.89; P = .03; Figure 2). The asso-
ciated specificity for predicting macrosomia was signifi-
cantly higher for 2D biometry (85% versus 66%; P < .01).
Sensitivity was nominally higher for 3D sonography, but
the difference was not statistically significant (59% versus
71%; P = .22; Table 2). The PPVs (40% versus 27%) and
NPVs (92% versus 93%) were not significantly different
for the two methods in this cohort.
Seven of the 115 women (6.1%) had macrosomic
neonates with birth weights of 4500 g or higher (secondary
outcome). Two-dimensional biometry appeared nomi-
nally superior to 3D biometry for predicting macrosomia
of 4500 g or higher, but the difference was not statistically
significant (area under the ROC curve, 0.90 [95% CI, 0.81,
0.99] versus 0.83 [95% CI, 0.68, 0.98]; P = .44; Figure 3).
The associated specificity for predicting macrosomia of
4500 g or higher was significantly higher for 2D biometry
(99% versus 85%; P < .01), whereas sensitivity was nomi-
nally higher for 3D biometry, but the difference was not
statistically significant (24% versus 53%; P = .25; Table 3).
Discussion
In this study using the gestation-adjusted projection
method approximately 2 weeks before delivery, we found
that a formula based on 2D biometry was overall superior
to a formula incorporating 3D fractional thigh volume for
predicting birth weight and fetal macrosomia in women
with diabetes. Specificity was significantly higher for 2D
biometry, whereas the difference in sensitivity was not
statistically significant. Systematic bias and random error
were both significantly lower for 2D biometry.
Pagani et al16 conducted a similar prospective study
comparing the accuracy of model 6 from Lee et al,14 which
incorporates 3D factional thigh volume, to the Hadlock
formula in 125 Italian women with gestational diabetes.
Similar to our study, they found no differences in sensitivity
for predicting macrosomia. However, in contrast to our
study, they found that the 3D Lee formula (not the 2D
Hadlock formula) had lower systematic bias and higher
specificity for predicting macrosomia. It is unclear why our
results differed from those of Pagani et al with regard to
systematic bias and random error for predicting birth weight
and specificity for macrosomia. Both studies included only
diabetic pregnancies and compared the accuracy predict-
ing fetal macrosomia using Hadlock’s 2D formula IV and
Lee’s 3D formula 6 with gestation-adjusted projection
based on the method proposed by Mongelli and Gardosi.19
In addition, patients had 2D and 3D sonographic biometry
within similar gestational age windows, and the primary out-
come was macrosomia of 4000 g or higher in both studies.
However, although Pagani et al16 included only gestational
diabetics, we included both gestational and pregestational
diabetics. Furthermore, the racial makeup of the sample in
the Pagani study was presumably white women who were
mostly of normal weight, whereas our population was more
heterogeneous, consisting largely of African American and
obese gravidas. Pagani et al16 also used the 1-step, 2-hour,
75-g oral glucose tolerance test to screen for gestational
diabetes, whereas we used the 2-step screening method.
Our study had several strengths. The prospective design
with sonographic biometry performed by 2 experienced
sonographers credentialed in obstetrics and gynecology
Tuuli et al—3D Versus 2D Sonographic Biometry in Diabetic Pregnancies
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Figure 1. Bland-Altman plots of agreement between birth weight
and projected estimated fetal weight for 2D (A) and 3D (B) biometry.
The shaded areas are the 95% limits of agreement (n = 115).
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was a key strength of the study. Furthermore, measurement
of the fractional thigh volumes, which have been shown to
be reproducible among blinded examiners, was performed
twice and averaged. We also used rigorous methods to
comprehensively assess the systematic bias, random bias,
and predictive ability of 2D and 3D biometry for macro-
somia. We used Bland-Altman analysis to assess agreement
between projected estimates and birth weight, which is
important because the mean percentage error alone does not
capture the full range of differences between the projected
estimates and birth weights. We assessed the predictive
accuracy of birth weight of 4500 g or higher in addition to
birth weight of 4000 g or higher, which is clinically relevant
because 4500 g is the more common fetal weight cutoff at
which consideration of cesarean delivery is recommended
in women with diabetes.9 Furthermore, we included only
women who delivered after 38 weeks to maximize the
occurrence of fetal macrosomia.
There were limitations that should be considered when
interpreting our results. We extrapolated estimated birth
weight using the gestation-adjusted projection method,
which relies on the assumption that the ratio of actual fetal
weight to the median fetal weight at the same gestational
age is constant in the third trimester. Although this assump-
tion is reasonable within the fairly narrow interval between
sonography and delivery and has been used in other
studies,19 it has not been formally validated. In addition,
it is plausible that poor glycemic control in our sample,
which was made up of both pregestational and gestational
diabetics, could have violated this assumption, which may
have accounted for the larger systematic bias we observed
especially for the 3D method.
We did not perform a sample size estimation a priori,
since our sample size was limited by the enrollment in the
primary study. Our sample size of 115 was comparable to
prior studies, but it was still relatively small, which may have
contributed to the relatively wide CIs around our estimates.
The associated low statistical power may also have been
the reason for our inability to show statistically significant
differences even for some estimates that were nominally
vastly different. Although the random error of 10.2% for
the 2D method was consistent with what has been pub-
lished in the literature for the Hadlock model, the random
prediction error of 17.2% for the 3D method is much
higher than that reported in other studies.15,16 The study by
Pagani et al,16 using the gestation-adjusted projection
Table 2. Predictive Characteristics of 2D and 3D Sonography for 
Macrosomia of Greater Than 4000 g in Diabetic Pregnancies (n = 115)
Projected 2D Projected 3D 
Predictive Measure Estimate Estimate
Sensitivity (95% CI), % 59 (33, 82) 71 (44, 90)
Specificity (95% CI), % 85 (76, 91) 66 (56, 76)
Accuracy (95% CI), % 72 (59, 84) 69 (56, 81)
PPV (95% CI), % 40 (21, 61) 27 (15, 42)
NPV (95% CI), % 92 (85, 97) 93 (84, 98)
Table 3. Predictive Characteristics of 2D and 3D Sonography for 
Macrosomia of Greater Than 4500 g in Diabetic Pregnancies (n = 115)
Projected 2D Projected 3D 
Predictive Measure Estimate Estimate
Sensitivity (95% CI), % 24 (7, 50) 53 (28, 77)
Specificity (95% CI), % 99 (94, 100) 85 (76, 91)
Accuracy (95% CI), % 61 (56, 82) 69 (56, 82)
PPV (95% CI), % 80 (28, 100) 38 (19, 59)
NPV (95% CI), % 88 (81, 94) 91 (83, 96)
Figure 2. Receiver operating characteristic curves of 2D and 3D sonog-
raphy for predicting macrosomia of greater than 4000 g in diabetic
pregnancies (n = 115).
Figure 3. Receiver operating characteristic curves of 2D and 3D sonog-
raphy for predicting macrosomia of greater than 4500 g in diabetic
pregnancies (n = 115).
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method about 3 weeks before delivery, reported a 5.0%
random error in gestational diabetics. Similarly, Lee et al15
reported random error values of 6.6% and 5.8% for all
neonates and macrosomic neonates weighing 4000 g or
higher, respectively, in a study estimating fetal weight
within 4 days of delivery based on the 3D method without
gestation-adjusted projection. It is unlikely that the use of
the gestation-adjusted projection method is an explanation
for this observation, since lower random errors were
observed in one study that employed it and another study
that did not. On the other hand, because random error is a
reflection of variability in measurements, the larger random
error in our study suggests overall larger measurement
errors, which may have been attributable, at least in part, to
the high prevalence of obesity (65.2%) in our cohort.
Prediction of fetal macrosomia in women with dia-
betes remains challenging.23 Although the fetal fat mass
constitutes only 14% of birth weight, it accounts for as much
as 46% of the variance in birth weight.24 Moreover, adipose
tissue is subject to major changes when conditions associ-
ated with accelerated growth such as diabetes are present.
Thus, it is likely that better quantification of specific fetal
soft tissue such as fat would allow for improved estimation
of birth weight and prediction of macrosomia.
In conclusion, the results of this prospective study show
that Hadlock’s 2D formula was superior to the 3D method
for predicting birth weight and macrosomia in diabetic
women when used approximately 2 weeks before delivery,
based on the gestation-adjusted projection method. Further
studies should include a larger sample size and determine
whether quantification of specific fetal soft tissue such as fat
and addition of patient characteristics will improve predic-
tion of macrosomia. Until then, our data suggest that 2D
sonography should remain the standard of care for predict-
ing birth weight and macrosomia in diabetic pregnancies.
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